ACM
BEAM icon

Alessandra Capital Management’s Beam Therapeutics BEAM Stock Holding History

Alessandra Capital Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95M Sell
56,945
-5,661
-9% -$171K 1.38% 18
2026
Q1 		$1.49M Buy
62,606
+11,531
+23% +$320K 1.27% 23
2025
Q4 		$1.42M Buy
+51,075
New +$1.3M 1.26% 22

Other funds holding BEAM

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
PIM
Peregrine Investment Management Toronto, Ontario, Canada $235M AUM 131.85% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

Alessandra Capital Management's BEAM Position: Q2 2026 in Review

Alessandra Capital Management reduced its Beam Therapeutics (BEAM) stake by 9% in Q2 2026, selling an estimated $171K and leaving 56,945 shares worth $1.95M. The position accounts for 1.38% of the portfolio, ranked #18.

Alessandra Capital Management first reported a position in BEAM in Q4 2025 and has held it in 3 quarters since. 59 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Alessandra Capital Management held 56,945 shares of Beam Therapeutics worth $1.95M as of Q2 2026.
  • Alessandra Capital Management sold 5,661 Beam Therapeutics shares in Q2 2026, an estimated $171K.
  • Beam Therapeutics made up 1.38% of Alessandra Capital Management's portfolio in Q2 2026, its #18 holding.
  • Alessandra Capital Management first reported a position in Beam Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 59 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Alessandra Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.